A randomized, double-blind, placebo-controlled trial on efficacy and safety of blumea balsamifera (Sambong) on prognostic parameters and qualityof- life of chronic heart failure patients

Authors
Category Primary study
ConferenceEuropean Heart Journal, Supplement
Year 2019
This article has no abstract
Epistemonikos ID: ada9d73413564b84872129bd49bfd3b8ead33bee
First added on: Apr 30, 2026